VN
EN
Close Menu
Home page
About Us
About Imexpharm
Our Culture
Our Journey
People
Potential
News
Imexpharm News
Events
Specialized
Investor Events
Community Activities
Products
Product Groups
Products A-Z
Investors
Investor events
AGM
BOD Resolutions
Information Disclosure
IR News
Financial Statements
Annual Reports
Sustainability Reports
Search All
Corporate Governance
Search All
Our Charter
Management Regulations
Corporate Governance Reports
Prospectus
Code of Conduct
Community
Careers
Media
Contact
Home
Investors
Investor documents
Information Disclosure
IMP - Documents to collect GMS's opinions in writing
07/25/2024
IMP - Official letter of the SSC regarding receipt of documents reporting on issuance of shares to increase charter capital from owner's equity capital
08/30/2024
IMP - Personnel change announcement - Appointment of Deputy General Director, in charge of Chief Commercial Officer
08/17/2024
IMP - BOD’s Decision re. the appointment of Ms. Le Nu Minh Hoai as Deputy General Director, in charge of Chief Commercial Officer
08/17/2024
IMP - BOD Resolution No. 13 on implementing share issuance to increase charter capital
08/13/2024
IMP - Resolution of the GMS to collect shareholders' written opinions
08/08/2024